Malignant Uterine Corpus Neoplasm — Trials

Malignant Uterine Corpus Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,571 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 411
Recruiting: 226
Ph III recruiting: 25
Growth YoY: +3.1%
Industry share: 31%
Top sponsor: National Cancer Institute (NCI)
Termination share: 27.6%
Trials / 1,000 deaths: 50.2 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (168)

clinicaltrialsPublishedShowing 101–102 of 102 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04956601	Adjuvant Radiotherapy in Patients With Early Endometrial Cancer	not yet recruiting	N/A	480	Peking University Third HospitalOTHER	1	Jul 9, 2021	clinicaltrials
NCT04227249	3 Year Recurrence Free Survival in Ultra-low-risk Endometrial Cancer(TREE PRO)	not yet recruiting	—	153	Seoul National University HospitalOTHER	0	Jan 14, 2020